Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma

BACKGROUND: The Response Evaluation Criteria in Solid Tumors (RECIST) for computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However, it does not reflect the pathological treatment response (PTR) of pancreatic ductal adenocarcinoma (PDAC). The Positron Emission Tomograp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokose, Takahiro, Kitago, Minoru, Matsusaka, Yohji, Masugi, Yohei, Shinoda, Masahiro, Yagi, Hiroshi, Abe, Yuta, Oshima, Go, Hori, Shutaro, Endo, Yutaka, Toyama, Kenji, Iwabuchi, Yu, Takemura, Ryo, Ishii, Ryota, Nakahara, Tadaki, Okuda, Shigeo, Jinzaki, Masahiro, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300404/
https://www.ncbi.nlm.nih.gov/pubmed/32281301
http://dx.doi.org/10.1002/cam4.3044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300404/
https://www.ncbi.nlm.nih.gov/pubmed/32281301
http://dx.doi.org/10.1002/cam4.3044

Ejemplares similares